GMT — Genomtec SA Cashflow Statement
0.000.00%
Last trade - 00:00- PLN91.89m
- PLN83.96m
- PLN0.00m
Annual cashflow statement for Genomtec SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | PRESS | ARS | ARS | ARS |
| Standards: | IFRS | — | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.9 | -5.27 | -11.9 | -9.01 | -11.2 |
| Depreciation | |||||
| Non-Cash Items | 9.04 | -0.038 | 4.84 | 0.011 | 0.001 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.852 | -0.492 | 3.05 | -0.106 | 2.16 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.5 | -5.48 | -3.6 | -7.95 | -6.72 |
| Capital Expenditures | -0.127 | -0.218 | -4.33 | -3.53 | -0.059 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.051 | 0 | — | -0.277 | -0.321 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.076 | -0.218 | -4.33 | -3.8 | -0.38 |
| Financing Cash Flow Items | -0.018 | -0.022 | -0.191 | -0.1 | -0.11 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 8.45 | -0.218 | 10.7 | 11.8 | 9.62 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.87 | -5.92 | 2.77 | 0.042 | 2.53 |